Venter F - Search Results

1

The association between HIV (treatment), pregnancy serum lipid concentrations and pregnancy outcomes: a systematic review.

Harmsen MJ, Browne JL, Venter F, Klipstein-Grobusch K, Rijken MJ. Harmsen MJ, et al. Among authors: venter f. BMC Infect Dis. 2017 Jul 11;17(1):489. doi: 10.1186/s12879-017-2581-8. BMC Infect Dis. 2017. PMID: 28697741 Free PMC article.

2

High pregnancy intentions and missed opportunities for patient-provider communication about fertility in a South African cohort of HIV-positive women on antiretroviral therapy.

Schwartz SR, Mehta SH, Taha TE, Rees HV, Venter F, Black V. Schwartz SR, et al. Among authors: venter f. AIDS Behav. 2012 Jan;16(1):69-78. doi: 10.1007/s10461-011-9981-3. AIDS Behav. 2012. PMID: 21656145

3

Starter packs versus full prescription of antiretroviral drugs for postexposure prophylaxis: a systematic review.

Ford N, Venter F, Irvine C, Beanland RL, Shubber Z. Ford N, et al. Among authors: venter f. Clin Infect Dis. 2015 Jun 1;60 Suppl 3:S182-6. doi: 10.1093/cid/civ093. Clin Infect Dis. 2015. PMID: 25972501 Review.

4

HIV and risk of cardiovascular disease in sub-Saharan Africa: Rationale and design of the Ndlovu Cohort Study.

Vos A, Tempelman H, Devillé W, Barth R, Wensing A, Kretzschmar M, Klipstein-Grobusch K, Hoepelman A, Tesselaar K, Aitken S, Madzivhandila M, Uiterwaal C, Venter F, Coutinho R, Grobbee DE. Vos A, et al. Among authors: venter f. Eur J Prev Cardiol. 2017 Jul;24(10):1043-1050. doi: 10.1177/2047487317702039. Epub 2017 Apr 5. Eur J Prev Cardiol. 2017. PMID: 28379043 Free article.

5

The triumph of HIV treatment: another new antiretroviral.

Boffito M, Venter F. Boffito M, et al. Among authors: venter f. Lancet. 2017 Nov 4;390(10107):2019-2021. doi: 10.1016/S0140-6736(17)32297-3. Epub 2017 Aug 31. Lancet. 2017. PMID: 28867498 No abstract available.

6

The unexpected success of NRTIs in second-line treatment.

Hill AM, Venter F. Hill AM, et al. Among authors: venter f. Lancet Infect Dis. 2018 Jan;18(1):3-5. doi: 10.1016/S1473-3099(17)30631-X. Epub 2017 Nov 3. Lancet Infect Dis. 2018. PMID: 29108798 Free article. No abstract available.

7

CYP2B6 Genotype and Weight Gain Differences Between Dolutegravir and Efavirenz.

Griesel R, Maartens G, Chirehwa M, Sokhela S, Akpomiemie G, Moorhouse M, Venter F, Sinxadi P. Griesel R, et al. Among authors: venter f. Clin Infect Dis. 2021 Dec 6;73(11):e3902-e3909. doi: 10.1093/cid/ciaa1073. Clin Infect Dis. 2021. PMID: 32960272 Free PMC article. Clinical Trial.

8

Antiretroviral therapy uptake and predictors of virological failure in patients with HIV receiving first-line and second-line regimens in Johannesburg, South Africa: a retrospective cohort data analysis.

Gumede SB, Venter F, de Wit J, Wensing A, Lalla-Edward ST. Gumede SB, et al. Among authors: venter f. BMJ Open. 2022 Apr 15;12(4):e054019. doi: 10.1136/bmjopen-2021-054019. BMJ Open. 2022. PMID: 35428623 Free PMC article.

9

Pharmacogenetics of Dolutegravir Plasma Exposure Among Southern Africans With Human Immunodeficiency Virus.

Cindi Z, Kawuma AN, Maartens G, Bradford Y, Venter F, Sokhela S, Chandiwana N, Wasmann RE, Denti P, Wiesner L, Ritchie MD, Haas DW, Sinxadi P. Cindi Z, et al. Among authors: venter f. J Infect Dis. 2022 Nov 1;226(9):1616-1625. doi: 10.1093/infdis/jiac174. J Infect Dis. 2022. PMID: 35512135 Free PMC article.

10

Barriers to Uptake of Long-Acting Antiretroviral Products for Treatment and Prevention of HIV in Low- and Middle-Income Countries (LMICs).

Kityo C, Cortes CP, Phanuphak N, Grinsztejn B, Venter F. Kityo C, et al. Among authors: venter f. Clin Infect Dis. 2022 Nov 21;75(Suppl 4):S549-S556. doi: 10.1093/cid/ciac752. Clin Infect Dis. 2022. PMID: 36410377

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

150 results

Search Page